Your session is about to expire
← Back to Search
Project PEER: Understanding the Lung Cancer Patient ExperiEnce (PEER Trial)
Verified Trial
N/A
Recruiting
Led By Upal Basu Roy, PhD, MPH
Research Sponsored by LUNGevity Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adults with self-reported lung cancer diagnosis or caregiver of someone with a self-reported lung cancer diagnosis (patient has to be alive)
Ability to read and answer questions in English
Timeline
Screening 0 days
Treatment 12 months
Follow Up 0 days
Awards & highlights
PEER Trial Summary
This trial seeks to learn how treatments for lung cancer affect quality of life. Join by emailing study team to get access to the study website & get an e-gift card each month for 12 months for completing surveys. #LungCancer #Participation #ResearchStudy
Who is the study for?
This study is for individuals with lung cancer, including those with a specific type called lung carcinoid tumor, as well as their caregivers. Participants should be willing to share their experiences through monthly online surveys over the course of a year.Check my eligibility
What is being tested?
There are no medical treatments being tested in this trial. Instead, participants will complete online surveys designed to gather information on how living with lung cancer affects quality of life from both patients' and caregivers' perspectives.See study design
What are the potential side effects?
Since there are no medical interventions involved in this study, there are no side effects associated with treatment. The main consideration for participants is the time commitment required to complete the monthly surveys.
PEER Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPEER Trial Timeline
Screening ~ 0 days0 visits
Treatment ~ 12 months0 visits
Follow Up ~ 0 days0 visits
Screening ~ 0 days
Treatment ~ 12 months
Follow Up ~0 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Explore guideline concordant care
Explore impacts of different classes of therapies
Explore patient-reported functioning, symptoms, side effects and overall quality of life
Other outcome measures
Impact of the pandemic on access to treatment
PEER Trial Design
2Treatment groups
Experimental Treatment
Group I: PatientsExperimental Treatment1 Intervention
Individuals who have been diagnosed with lung cancer. Individuals with all stages of lung cancer and individuals who have reached no evidence of disease (NED).
Group II: CaregiversExperimental Treatment1 Intervention
Family and friends who provide care for someone who has been diagnosed with lung cancer
Find a Location
Who is running the clinical trial?
NovartisIndustry Sponsor
1,614 Previous Clinical Trials
2,720,052 Total Patients Enrolled
LUNGevity FoundationLead Sponsor
7 Previous Clinical Trials
346 Total Patients Enrolled
AmgenIndustry Sponsor
1,383 Previous Clinical Trials
1,378,621 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Patients
- Group 2: Caregivers
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 0 Weeks to process to see if you qualify in this trial.
- Treatment: You will receive the treatment for 12 Months
- Follow Ups: You may be asked to continue sharing information regarding the trial for 0 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger